Dependence of Reactive Oxygen Species and FLICE Inhibitory Protein on Lipofectamine-Induced Apoptosis in Human Lung Epithelial Cells
Public Domain
-
2008/06/01
-
Details
-
Personal Author:Azad N ; Iyer AKV ; Kongkaneramit L ; Lu Y ; Rojanasakul Y ; Sarisuta N ; Wang Y ; Azad N ; Iyer AKV ; Kongkaneramit L ; Lu Y ; Rojanasakul Y ; Sarisuta N ; Wang Y
-
Description:Cationic liposomes such as Lipofectamine (LF) are widely used as nonviral gene delivery vectors; however, their clinical application is limited by their cytotoxicity. These agents have been shown to induce apoptosis as the primary mode of cell death, but their mechanism of action is not well understood. The present study investigated the mechanism of LF-induced apoptosis and examined the role of reactive oxygen species (ROS) in this process. We found that LF induced apoptosis of human epithelial H460 cells through a mechanism that involves caspase activation and ROS generation. Inhibition of caspase activity by pan-caspase inhibitor (z-VAD-fmk) or by specific caspase-8 inhibitor (z-IETD-fmk) or caspase-9 inhibitor (z-LEHD-fmk) inhibited the apoptotic effect of LF. Overexpression of FLICE-inhibitory protein (FLIP) or B-cell lymphoma-2, which are known inhibitors of the extrinsic and intrinsic death pathways, respectively, similarly inhibited apoptosis by LF. Induction of apoptosis by LF was shown to require ROS generation because its inhibition by ROS scavengers or by ectopic expression of antioxidant enzyme superoxide dismutase and glutathione peroxidase strongly inhibited the apoptotic effect of LF. Electron spin resonance studies showed that LF induced multiple ROS; however, superoxide was found to be the primary ROS responsible for LF-induced apoptosis. The mechanism by which ROS mediate the apoptotic effect of LF involves down-regulation of FLIP through the ubiquitination pathway. In demonstrating the role of FLIP and ROS in LF death signaling, we document a novel mechanism of apoptosis regulation that may be exploited to decrease cytotoxicity and increase gene transfection efficiency of cationic liposomes. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0022-3565
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:325
-
Issue:3
-
NIOSHTIC Number:nn:20033880
-
Citation:J Pharmacol Exp Ther 2008 Jun; 325(3):969-977
-
Contact Point Address:Dr. Yon Rojanasakul, West Virginia University, Health Sciences Center, Department of Pharmaceutical Sciences, P.O. Box 9530, Morgantown, WV 26506
-
Email:yrojan@hsc.wvu.edu
-
Federal Fiscal Year:2008
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:Journal of Pharmacology and Experimental Therapeutics
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e38a6141665d9108eef03ad60d85e9099ca3cb17507e7899f5d16d48ab83191ccb9bc361582bb70f6b436818c58bcf8b81278853b6abdd343de3026bbf129079
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like